Craig H. Selzman
( out of 150 reviews )

Craig H. Selzman, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

University of Utah Hospital

Cardiothoracic Surgery
50 N Medical Dr
Salt Lake City , UT 84132
Get Directions

Dr. Craig Selzman is the Dr. Russell M. Nelson and Dantzel W. Nelson Presidential Endowed Chair as well as Professor and Chief of the Division of Cardiothoracic Surgery at the University of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training at the University of Colorado and is Board-Certified in both fields. Dr. Selzman was on faculty at the University of North Carolina before joining the faculty at University of Utah in 2008.


Clinically, Dr. Selzman is the Surgical Director of the Cardiac Mechanical Support and Heart Transplant program and serves as the Medical Director of the Transplant Service Line for the University Hospital. In addition to his role in the advanced Heart Failure and artificial heart program, he specializes in complex valvular heart disease including reoperative heart surgery, adult congenital heart disease, and aortic root reconstruction. He is one of a few surgeons in the Mountain West with significant experience with minimally invasive heart surgery for a wide variety of disease, and, in particular, mitral valve repair.

Dr. Selzman is heavily involved with clinical research related to advanced heart failure, transplantation, and ventricular assist devices. He also has an active basic science collaboration with many of our researchers here at the University of Utah and is an Inverstigator at the Cardiovascular Research and Training Institute. Dr. Selzman is one of a handful of cardiothoracic surgeons that runs a translational science laboratory historically funded by the National Institute of Health. His research focus is related to examining mechanisms of heart recovery and ischemia-reperfusion injury.

Specialties

Board Certification

American Board of Surgery (Sub: General Surgery)
American Board of Thoracic Surgery (Thoracic Surg)

Patient Rating

4.9 /5
( out of 150 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

UNIVERSITY HOSPITAL

He is the best. We are lucky to have him at the U. He truly fulfills his role as the RMN chief of the department. No one better.

UH HOSPITALS AND CLINICS

He explained everything thorouglhly in a way that was understandable.

UH HOSPITALS AND CLINICS

Very caring Dr. I felt very lucky to have him perform my surgery.

UH HOSPITALS AND CLINICS

He made me feel at ease. Easy to talk to.

UH HOSPITALS AND CLINICS

He's the best in the business. I was so fortunate to be able to fit on his schedule/caseload.

UNIVERSITY HOSPITAL

Qualified

UNIVERSITY HOSPITAL

Dr Selzman is an amazing doctor and was determined to ensure I understood everything needing his and my attention

UNIVERSITY HOSPITAL

AWESOME

UNIVERSITY HOSPITAL

The Doctor was very kind and gave us all the information to help make our decision. We are looking forward to the next phase and meeting with the doctors in person!

Dr. Craig Selzman is the Dr. Russell M. Nelson and Dantzel W. Nelson Presidential Endowed Chair as well as Professor and Chief of the Division of Cardiothoracic Surgery at the University of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training at the University of Colorado and is Board-Certified in both fields. Dr. Selzman was on faculty at the University of North Carolina before joining the faculty at University of Utah in 2008.


Clinically, Dr. Selzman is the Surgical Director of the Cardiac Mechanical Support and Heart Transplant program and serves as the Medical Director of the Transplant Service Line for the University Hospital. In addition to his role in the advanced Heart Failure and artificial heart program, he specializes in complex valvular heart disease including reoperative heart surgery, adult congenital heart disease, and aortic root reconstruction. He is one of a few surgeons in the Mountain West with significant experience with minimally invasive heart surgery for a wide variety of disease, and, in particular, mitral valve repair.

Dr. Selzman is heavily involved with clinical research related to advanced heart failure, transplantation, and ventricular assist devices. He also has an active basic science collaboration with many of our researchers here at the University of Utah and is an Inverstigator at the Cardiovascular Research and Training Institute. Dr. Selzman is one of a handful of cardiothoracic surgeons that runs a translational science laboratory historically funded by the National Institute of Health. His research focus is related to examining mechanisms of heart recovery and ischemia-reperfusion injury.

Board Certification and Academic Information

Academic Departments Surgery -Professor
Academic Divisions Cardiothoracic Surgery
Board Certification
American Board of Surgery (Sub: General Surgery)
American Board of Thoracic Surgery (Thoracic Surg)

Education history

Undergraduate Political Science - Amherst College B.A.
Professional Medical Medicine - Baylor College of Medicine M.D.
Internship Surgery - University of Colorado at Denver and Health Sciences Center Intern
Residency Surgery - University of Colorado at Denver and Health Sciences Center Resident
Residency Cardiothoracic Surgery - University of Colorado at Denver and Health Sciences Center Resident

Selected Publications

Journal Article

  1. Gray NA Jr, Selzman CH (2006). Current status of the total artificial heart. Am Heart J, 152(1), 4-10.
  2. Gray NA Jr, Selzman CH (2006). Current status of the total artificial heart. Am Heart J, 152(1), 4-10.
  3. Meng X, Ao L, Meldrum DR, Cain BS, Shames BD, Selzman CH, Banerjee A, Harken AH (1998). TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol, 275(2), R502-8.
  4. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, Harken AH, Meng X (1998). Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. Am J Physiol, 275(3), H1084-91.
  5. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, McIntyre RC Jr (1999). Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am J Physiol, 277(4), L769-76.
  6. Sheridan BC, Dinarello CA, Meldrum DR, Fullerton DA, Selzman CH, McIntyre RC Jr (1999). Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am J Physiol, 277(5), L861-7.
  7. Tonna JE, Selzman CH, Mallin MP, Smith BR, Youngquist ST, Koliopoulou A, Welt F, Stoddard KD, Nirula R, Barton R, Fair JF 3rd, Fang JC, McKellar S (2017). Development and Implementation of a Comprehensive, Multidisciplinary Emergency Department Extracorporeal Membrane Oxygenation Program. Ann Emerg Med, 70(1), 32-40.
  8. Selzman CH, Shames BD, McIntyre RC Jr, Banerjee A, Harken AH (1999). The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferation. Ann Thorac Surg, 67(5), 1227-31; discussion 1231-2.
  9. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH (2007). Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg, 84(1), 120-5.
  10. Selzman CH (2008). Invited commentary. Ann Thorac Surg, 85(2), 585-6.
  11. Stansfield WE, Andersen NM, Tang RH, Selzman CH (2009). Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg, 88(6), 1916-21.
  12. Selzman C (2010). Invited commentary. Ann Thorac Surg, 90(1), 123.
  13. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607.
  14. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013). Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg, 95(3), 870-5.
  15. Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH (2014). Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg, 97(4), 1364-71; discussion 1371-2.
  16. Selzman CH, Madden JL, Healy AH, McKellar SH, Koliopoulou A, Stehlik J, Drakos SG (2015). Bridge to removal: a paradigm shift for left ventricular assist device therapy. Ann Thorac Surg, 99(1), 360-7.
  17. Healy AH, Koliopoulou A, Drakos SG, McKellar SH, Stehlik J, Selzman CH (2015). Patient-controlled conditioning for left ventricular assist device-induced myocardial recovery. Ann Thorac Surg, 99(5), 1794-6.
  18. Selzman CH, Desjardins G, Patel AN, Davis E, Dick S, Stehlik J (2012). Complications associated with the use of left ventricular assist device therapy in an adult patient with Ebstein's anomaly. Ann Thorac Surg, 93(1), 297-9.
  19. Selzman CH, Whitehill TA, Shames BD, Pulido EJ, Cain BS, Harken A (1998). The biology of estrogen-mediated repair of cardiovascular injury. The Annals of thoracic surgery, 65(3), 868-74.
  20. Selzman CH, Miller SA, Harken A (2001). Therapeutic implications of inflammation in atherosclerotic cardiovascular disease. The Annals of thoracic surgery, 71(6), 2066-74.
  21. Selzman C (2012). Invited commentary. The Annals of thoracic surgery, 94(6), 2024.
  22. Selzman CH, Desjardins G, Patel AN, Davis E, Dick S, Stehlik (2012). Complications associated with the use of left ventricular assist device therapy in an adult patient with Ebstein's anomaly. The Annals of thoracic surgery, 93(1), 297-9.
  23. Selzman C (2011). Invited commentary. The Annals of thoracic surgery, 92(1), 153-4.
  24. Selzman (2009). Invited commentary. The Annals of thoracic surgery, 88(1), 53.
  25. Selzman (2009). Invited commentary. The Annals of thoracic surgery, 87(3), 819.
  26. Selzman (2007). Invited commentary. The Annals of thoracic surgery, 83(5), 1758-9.
  27. Selzman C (2006). Invited commentary. The Annals of thoracic surgery, 82(4), 1418-9.
  28. Selzman CH, Miller SA, Harken A (2001). Therapeutic implications of inflammation in atherosclerotic cardiovascular disease. The Annals of thoracic surgery, 71(6), 2066-74.
  29. Selzman CH, Whitehill TA, Shames BD, Pulido EJ, Cain BS, Harken A (1998). The biology of estrogen-mediated repair of cardiovascular injury. The Annals of thoracic surgery, 65(3), 868-74.
  30. Javan H, Li L, Schaaf CL, Lee YS, Salama ME, Dinarello CA, Selzman C (2021). Interleukin 1 receptor antagonism abrogates acute pressure-overload induced murine heart failure. The Annals of thoracic surgery,
  31. Selzman CH, Turner AS, Gaynor JS, Miller SA, Monnet E, Harken A (2002). Inhibition of intimal hyperplasia using the selective estrogen receptor modulator raloxifene. Archives of surgery (Chicago, Ill., 137(3), 333-6.
  32. Shames BD, Selzman CH, Meng X, Meldrum DR, Cain BS, Harken A (1998). Genes don't count. Archives of surgery (Chicago, Ill., 133(6), 667-9.
  33. Selzman CH, Miller SA, Zimmerman MA, Harken A (2001). The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Archives of surgery (Chicago, Ill., 136(3), 286-90.
  34. Zimmerman MA, Selzman CH, Cothren C, Sorensen AC, Raeburn CD, Harken A (2003). Diagnostic implications of C-reactive protein. Archives of surgery (Chicago, Ill., 138(2), 220-4.
  35. Selzman CH, Miller SA, Zimmerman MA, Harken A (2001). The case for beta-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Archives of surgery (Chicago, Ill., 136(3), 286-90.
  36. Shames BD, Selzman CH, Meng X, Meldrum DR, Cain BS, Harken A (1998). Genes don't count. Archives of surgery (Chicago, Ill., 133(6), 667-9.
  37. Stanfield JR, Selzman C (2013). In vitro hydrodynamic analysis of pin and cone bearing designs of the Jarvik 2000 adult ventricular assist device. Artificial organs, 37(9), 825-33.
  38. Kouretas PC, Kaza AK, Burch PT, Witte MK, Clayson SE, Everitt MD, Selzman C (2009). Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artificial organs, 33(11), 1002-4.
  39. Kouretas PC, Kaza AK, Burch PT, Witte MK, Clayson SE, Everitt MD, Selzman C (2009). Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artificial organs, 33(11), 1002-4.
  40. Bhati RS, Sheridan BC, Mill MR, Selzman C (2005). Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome. The Journal of heart and lung transplantation, 24(12), 2286-9.
  41. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund D (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. The Journal of heart and lung transplantation, 28(8), 838-42.
  42. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik (2010). Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. The Journal of heart and lung transplantation, 29(3), 235-9.
  43. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury A (2011). Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?. The Journal of heart and lung transplantation, 30(2), 144-50.
  44. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation, 30(8), 854-61.
  45. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond M (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. The Journal of heart and lung transplantation, 31(1), 46-51.
  46. Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman C (2016). Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices--An analysis of the International Society for Heart and Lung Transplantation Transplant Registry. The Journal of heart and lung transplantation, 35(1), 34-39.
  47. Hammond MEH, Revelo MP, Miller DV, Snow GL, Budge D, Stehlik J, Molina KM, Selzman CH, Drakos SG, Rami A A, Nativi-Nicolau JN, Reid BB, Kfoury A (2016). ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis. The Journal of heart and lung transplantation, 35(3), 320-325.
  48. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J, Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. The Journal of heart and lung transplantation, 35(8), 1024-30.
  49. McKellar SH, Bowen ME, Baird BC, Raman S, Cahill BC, Selzman C (2016). Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant. The Journal of heart and lung transplantation, 35(11), 1289-1294.
  50. Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, Selzman CH, Fang JC, Lund LH, Stehlik (2017). Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. The Journal of heart and lung transplantation, 36(4), 407-417.
  51. Selzman CH, Chang PP, Vernon-Platt T, Bowen A, Kowalczyk S, Sherican B (2007). Use of the Jarvik 2000 continous flow left ventricular assist device for acute myocardial infarction and cardiogenic shock. The Journal of heart and lung transplantation, 26(7), 756-8.
  52. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. The Journal of heart and lung transplantation, 38(8), 858-869.
  53. Selzman CH, Chang PP, Vernon-Platt T, Bowen A, Kowalczyk S, Sheridan B (2007). Use of the Jarvik 2000 continuous flow left ventricular assist device for acute myocardial infarction and cardiogenic shock. The Journal of heart and lung transplantation, 26(7), 756-8.
  54. Editors., Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG, Contributing Authors., Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J, Reviewers., Schueler S, D'Alessandro D (2020). American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. The Journal of heart and lung transplantation, 39(3), 187-219.
  55. Reznikov LL, Fantuzzi G, Selzman CH, Shames BD, Barton HA, Bell H, McGregor JA, Dinarello C (1999). Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biology of reproduction, 60(5), 1231-8.
  56. Bouabdallaoui N, Stevens SR, Doenst T, Wrobel K, Bouchard D, Deja MA, Michler RE, Chua YL, Kalil RAK, Selzman CH, Daly RC, Sun B, Djokovic LT, Sopko G, Velazquez EJ, Rouleau JL, Lee KL, Al-Khalidi HR, STICH Trial Investigators (2018). Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. Journal of cardiothoracic and vascular anesthesia, 32(3), 1256-1263.
  57. Silverton NA, Patel R, Zimmerman J, Ma J, Stoddard G, Selzman CH, Morrissey C (2018). Intraoperative Transesophageal Echocardiography and Right Ventricular Failure After Left Ventricular Assist Device Implantation. Journal of cardiothoracic and vascular anesthesia, 32(5), 2096-2103.
  58. Khan MS, Yamashita K, Sharma V, Ranjan R, Selzman CH, Dosdall D (2020). Perioperative Biomarkers Predicting Postoperative Atrial Fibrillation Risk After Coronary Artery Bypass Grafting: A Narrative Review. Journal of cardiothoracic and vascular anesthesia, 34(7), 1933-1941.
  59. Moore B, Morgan N, Selzman C, Zimmerman (2020). Successful Use of Limited Transthoracic Echocardiography to Guide Veno-venous Extracorporeal Membrane Oxygenator Placement in a Patient With Coronavirus Disease 2019. Journal of cardiothoracic and vascular anesthesia, 34(12), 3491-3493.
  60. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg A (2009). Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood, 114(23), 4886-96.
  61. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu E (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR in biomedicine, 27(11), 1378-86.
  62. Selzman CH, Whitehill TA, Krupski W (1998). Thrombophilia and activated protein C resistance. Annals of vascular surgery, 12(6), 601-4.
  63. Selzman CH, Whitehill TA, Krupski W (1998). Thrombophilia and activated protein C resistance. Annals of vascular surgery, 12(6), 601-4.
  64. Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos S (2015). Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator?. Clinical transplantation, 29(9), 829-34.
  65. Raymond AL, Kfoury AG, Bishop CJ, Davis ES, Goebel KM, Stoker S, Selzman CH, Clayson SE, Smith H, Cowley CG, Alharethi R, Budge D, Reid B (2010). Obesity and left ventricular assist device driveline exit site infection. ASAIO journal (American Society for Artificial Internal Organs, 56(1), 57-60.
  66. Stanfield JR, Selzman CH, Pardyjak ER, Bamberg (2012). Flow characteristics of continuous-flow left ventricular assist devices in a novel open-loop system. ASAIO journal (American Society for Artificial Internal Organs, 58(6), 590-6.
  67. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman C (2014). Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO journal (American Society for Artificial Internal Organs, 60(5), 524-8.
  68. Bonios MJ, Selzman CH, Gilbert EM, McKellar SH, Koliopoulou A, Strege JL, Nativi JN, Fang JC, Stehlik J, Drakos S (2017). Exertional Angina Due To Fused Aortic Bioprosthesis During Left Ventricular Assist Device Support: Two Cases and Review of the Literature. ASAIO journal (American Society for Artificial Internal Organs, 63(1), e6-e9.
  69. Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader (2018). Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation. ASAIO journal (American Society for Artificial Internal Organs, 64(1), 38-42.
  70. Selzman CH, Koliopoulou A, Glotzbach JP, McKellar S (2018). Evolutionary Improvements in the Jarvik 2000 Left Ventricular Assist Device. ASAIO journal (American Society for Artificial Internal Organs, 64(6), 827-830.
  71. Hydren JR, Kithas AC, Park SH, Wever-Pinzon O, Selzman CH, Perry W, Vargas CAS, Stehlik J, Drakos SG, Richardson R (2020). Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. ASAIO journal (American Society for Artificial Internal Organs, 66(3), 291-299.
  72. McKellar SH, Koliopoulou A, Selzman C (2018). Atrial Fibrillation in Advanced Heart Failure Patients Receiving Left Ventricular Assist Devices. ASAIO journal (American Society for Artificial Internal Organs, 64(5), 573-574.
  73. Healy AH, Bowen M, McKellar SH, Koliopoulou A, Drakos SG, Selzman C (2021). Interleukin-1 Receptor Antagonism as Adjunct Therapy for Heart Failure Patients with Left Ventricular Assist Devices. ASAIO journal (American Society for Artificial Internal Organs, 67(8), e145-e147.
  74. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Current opinion in cardiology, 26(3), 245-55.
  75. Nativi-Nicolau J, Selzman CH, Fang JC, Stehlik (2014). Pharmacologic therapies for acute cardiogenic shock. Current opinion in cardiology, 29(3), 250-7.
  76. Koliopoulou A, McKellar SH, Rondina M, Selzman C (2016). Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets. Current opinion in cardiology, 31(3), 299-307.
  77. Selzman CH, Turner AS, Johnson SM, Cain BS, Harken AH, Whitehill T (1997). Chronic estrogen replacement inhibits aortic intimal hyperplasia independent of serum lipids. Journal of cardiac surgery, 12(4), 228-34.
  78. Selzman CH, Sheridan B (2007). Off-pump insertion of continuous flow left ventricular assist devices. Journal of cardiac surgery, 22(4), 320-2.
  79. McKellar SH, Koliopoulou A, Selzman C (2016). Minimally Invasive Temporary Right Ventricular Assist Device for Acute Right Ventricular Failure. Journal of cardiac surgery, 31(1), 69-71.
  80. Raeburn CD, Cleveland JC, Selzman CH, Harken A (2000). Ischemic preconditioning in myocardial revascularization with intermittent aortic cross-clamping. Journal of cardiac surgery, 15, 339-340.
  81. Selzman CH, Zimmerman MA, Campbell D (2003). ALCAPA in an adult with preserved left ventricular function. Journal of cardiac surgery, 18(1), 25-8.
  82. Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken A (2001). Clinical applications of cardiovascula angiogenesis. Journal of cardiac surgery, 16(6), 490-7.
  83. Selzman CH, Zimmerman MA, Campbell D (2003). ALCAPA in an adult with preserved left ventricular function. Journal of cardiac surgery, 18(1), 25-8.
  84. Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken A (2001). Clinical applications of cardiovascular angiogenesis. Journal of cardiac surgery, 16(6), 490-7.
  85. Harrison JD, Selzman CH, Thiesset HF, Box T, Hutson WR, Lu JK, Campsen J, Sorensen JB, Kim R (2014). Minimally invasive aortic valve replacement with orthotopic liver transplantation: report of a case. Surgery today, 44(3), 546-9.
  86. Sharma V, Glotzbach JP, Ryan J, Selzman C (2021). Evaluating Quality in Adult Cardiac Surgery. Texas Heart Institute journal, 48(1),
  87. Albright TN, Zimmerman MA, Selzman C (2002). Vasopressin in the cardiac surgery intensive care unit. American journal of critical care, 11(4), 326-32.
  88. Albright TN, Zimmerman MA, Selzman C (2002). Vasopressin in the cardiac surgery intensive care unit. American journal of critical care, 11(4), 326-30; quiz 331-2.
  89. Feldman AM, She L, McNamara DM, Mann DL, Bristow MR, Maisel AS, Wagner DR, Andersson B, Chiariello L, Hayward CS, Hendry P, Parker JD, Racine N, Selzman CH, Senni M, Stepinska J, Zembala M, Rouleau J, Velazquez EJ, Lee K (2015). Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials. Cardiology, 130(2), 69-81.
  90. Huang ZP, Ding Y, Chen J, Wu G, Kataoka M, Hu Y, Yang JH, Liu J, Drakos SG, Selzman CH, Kyselovic J, Qu LH, Dos Remedios CG, Pu WT, Wang D (2016). Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy. Cardiovascular research, 112(2), 543-554.
  91. Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA, Werman A, Harken AH, Dinarello CA, Banerjee (1999). Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. Circulation research, 84(8), 867-75.
  92. Selzman CH, Gaynor JS, Turner AS, Johnson SM, Horwitz LD, Whitehill TA, Harken A (1998). Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Circulation, 98(19), 2049-54.
  93. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li D (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41.
  94. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?. Circulation, 127(4), 452-62.
  95. Wrobel K, Stevens SR, Jones RH, Selzman CH, Lamy A, Beaver TM, Djokovic LT, Wang N, Velazquez EJ, Sopko G, Kron IL, DiMaio JM, Michler RE, Lee KL, Yii M, Leng CY, Zembala M, Rouleau JL, Daly RC, Al-Khalidi H (2015). Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. Circulation, 132(8), 720-30.
  96. Seidel T, Navankasattusas S, Ahmad A, Diakos NA, Xu WD, Tristani-Firouzi M, Bonios MJ, Taleb I, Li DY, Selzman CH, Drakos SG, Sachse F (2017). Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading. Circulation, 135(17), 1632-1645.
  97. Rao MP, Al-Khatib SM, Pokorney SD, She L, Romanov A, Nicolau JC, Lee KL, Carson P, Selzman CH, Stepinska J, Cleland JG, Tungsubutra W, Desvigne-Nickens PM, Sueta CA, Siepe M, Lang I, Feldman AM, Yii M, Rouleau JL, Velazquez EJ, STICH Trial Investigators (2017). Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure). Circulation, 135(12), 1136-1144.
  98. Hoffman M, Palioura D, Kyriazis ID, Cimini M, Badolia R, Rajan S, Gao E, Nikolaidis N, Schulze PC, Goldberg IJ, Kishore R, Yang VW, Bannister TD, Bialkowska AB, Selzman CH, Drakos SG, Drosatos (2021). Cardiomyocyte Krüppel-like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation, 143(11), 1139-1156.
  99. Birks EJ, Drakos SG, Patel SR, Lowes BD, Selzman CH, Starling RC, Trivedi J, Slaughter MS, Alturi P, Goldstein D, Maybaum S, Um JY, Margulies KB, Stehlik J, Cunningham C, Farrar DJ, Rame J (2020). Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation, 142(21), 2016-2028.
  100. Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos S (2020). The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 142(3), 259-274.
  101. Birks EJ, Drakos SG, Patel SR, Lowes BD, Selzman CH, Starling RC, Trivedi J, Slaughter MS, Alturi P, Goldstein D, Maybaum S, Um JY, Margulies KB, Stehlik J, Cunningham C, Farrar DJ, Rame J (2020). Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation, 142(21), 2016-2028.
  102. Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, Lewandowski E (2021). Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart. Circulation, 143(18), 1797-1808.
  103. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, Van der Meer JW, Dinarello C (2000). Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. European journal of immunology, 30(2), 541-9.
  104. Sardar P, Chatterjee S, Kundu A, Samady H, Owan T, Giri J, Nairooz R, Selzman CH, Heusch G, Gersh BJ, Abbott JD, Mukherjee D, Fang J (2016). Remote ischemic preconditioning in patients undergoing cardiovascular surgery: Evidence from a meta-analysis of randomized controlled trials. International journal of cardiology, 221, 34-41.
  105. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li D (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. Journal of the American College of Cardiology, 56(5), 382-91.
  106. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG, UCAR (Utah Cardiac Recovery Program) Investigators (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. Journal of the American College of Cardiology, 61(19), 1985-94.
  107. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos S (2014). Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. Journal of the American College of Cardiology, 64(15), 1602-12.
  108. Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirajan V, Haas DC, O'Connell JB, Boyle AJ, Farrar DJ, Rogers JG, ROADMAP Study Investigators (2015). Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. Journal of the American College of Cardiology, 66(16), 1747-1761.
  109. Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman C (2016). Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. Journal of the American College of Cardiology, 68(14), 1540-53.
  110. Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos S (2016). Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading. Journal of the American College of Cardiology, 68(16), 1741-1752.
  111. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang D (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of clinical investigation, 119(9), 2772-86.
  112. Khan MS, Lange M, Ranjan R, Sharma V, Glotzbach JP, Selzman C, Dosdall D (2021). Premature atrial stimulation accentuates conduction abnormalities in cardiac surgery patients that develop postoperative atrial fibrillation. Journal of electrocardiology, 69, 36-43.
  113. Kim SH, Reznikov LL, Stuyt RJ, Selzman CH, Fantuzzi G, Hoshino T, Young HA, Dinarello C (2001). Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain. Journal of immunology (Baltimore, Md., 166(1), 148-54.
  114. Selzman CH, McIntyre RC Jr, Shames BD, Whitehill TA, Banerjee A, Harken A (1998). Interleukin-10 inhibits human vascular smooth muscle proliferation. Journal of molecular and cellular cardiology, 30(4), 889-96.
  115. Pires KM, Buffolo M, Schaaf C, David Symons J, Cox J, Abel ED, Selzman CH, Boudina (2017). Activation of IGF-1 receptors and Akt signaling by systemic hyperinsulinemia contributes to cardiac hypertrophy but does not regulate cardiac autophagy in obese diabetic mice. Journal of molecular and cellular cardiology, 113, 39-50.
  116. Stanfield JR, Selzman C (2013). In vitro pulsatility analysis of axial-flow and centrifugal-flow left ventricular assist devices. Journal of biomechanical engineering, 135(3), 34505.
  117. Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Selzman CH, Banerjee A, Harken A (1997). Alpha-adrenergic activation of myocardial NF kappa B during hemorrhage. The Journal of surgical research, 69(2), 268-76.
  118. Selzman CH, Meldrum DR, Cain BS, Meng X, Shames BD, Ao L, Harken A (1998). Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferation. The Journal of surgical research, 80(2), 352-6.
  119. Selzman CH, Gaynor JS, Turner AS, Whitehill TA, Horwitz LD, Harken A (1998). Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1. The Journal of surgical research, 80(2), 380-5.
  120. Shames BD, Selzman CH, Pulido EJ, Meng X, Meldrum DR, McIntyre RC Jr, Harken AH, Banerjee (1999). LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. The Journal of surgical research, 83(1), 69-74.
  121. Cain BS, Meldrum DR, Meng X, Pulido EJ, Shames BD, Selzman CH, Banerjee A, Harken A (1999). Exogenous calcium preconditions myocardium from patients taking oral sulfonylurea agents. The Journal of surgical research, 86(2), 171-6.
  122. Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM, Harken A (2000). Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation. The Journal of surgical research, 90(1), 76-81.
  123. Shames BD, McIntyre RC Jr, Bensard DD, Pulido EJ, Selzman CH, Reznikov LL, Harken AH, Meng (2001). Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10. The Journal of surgical research, 99(2), 187-93.
  124. Zimmerman MA, Reznikov LL, Raeburn CD, Selzman C (2004). Interleukin-10 attenuates the response to vascular injury. The Journal of surgical research, 121(2), 206-13.
  125. Stansfield WE, Rojas M, Corn D, Willis M, Patterson C, Smyth SS, Selzman C (2007). Characterization of a model to independently study regression of ventricular hypertrophy. The Journal of surgical research, 142(2), 387-93.
  126. Andersen NM, Tang R, Li L, Javan H, Zhang XQ, Selzman C (2012). Inhibitory kappa-B kinase-ß inhibition prevents adaptive left ventricular hypertrophy. The Journal of surgical research, 178(1), 105-9.
  127. Andersen NM, Stansfield WE, Tang RH, Rojas M, Patterson C, Selzman C (2012). Recovery from decompensated heart failure is associated with a distinct, phase-dependent gene expression profile. The Journal of surgical research, 178(1), 72-80.
  128. McKellar SH, Javan H, Bowen ME, Liu X, Schaaf CL, Briggs CM, Zou H, Gomez AD, Abdullah OM, Hsu EW, Selzman C (2015). Animal model of reversible, right ventricular failure. The Journal of surgical research, 194(2), 327-333.
  129. Healy AH, McKellar SH, Drakos SG, Koliopoulou A, Stehlik J, Selzman C (2016). Physiologic effects of continuous-flow left ventricular assist devices. The Journal of surgical research, 202(2), 363-71.
  130. Tabachnick DR, Bowen ME, Stehlik J, Kfoury AG, Caine WT, Selzman CH, McKellar SH, Utah Cardiac Transplant Program (UCTP) (2017). Health characteristics of heart transplant recipients surviving into their 80s. The Journal of surgical research, 216, 99-102.
  131. Kang TS, Ko BS, Drakos SG, Stehlik J, Bott SI, Koliopoulou A, Tonna JE, Bowen ME, Stoddard K, Selzman CH, McKellar S (2018). Safety of long-distance transfers of patients on acute mechanical circulatory support. The Journal of surgical research, 224, 18-22.
  132. Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou T (2019). Longer Life or More Life: Choose One Please. The Journal of surgical research, 237, 126-128.
  133. Hickman AW, Lonardo NW, Mone MC, Presson AP, Zhang C, Barton RG, Selzman CH, Drakos SG, Koliopoulou A, McKellar S (2019). Acid Suppression to Prevent Gastrointestinal Bleeding in Patients With Ventricular Assist Devices. The Journal of surgical research, 234, 96-102.
  134. Bowen ME, Selzman CH, McKellar S (2019). Right Ventricular Involution: Big Changes in Small Hearts. The Journal of surgical research, 243, 255-264.
  135. Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello C (2003). Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis. The Journal of thoracic and cardiovascular surgery, 126(3), 688-93.
  136. Moss NC, Tang RH, Willis M, Stansfield WE, Baldwin AS, Selzman C (2008). Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection. The Journal of thoracic and cardiovascular surgery, 136(5), 1274-9.
  137. Stansfield WE, Charles PC, Tang RH, Rojas M, Bhati R, Moss NC, Patterson C, Selzman C (2009). Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. The Journal of thoracic and cardiovascular surgery, 137(1), 232-8, 238e1-8.
  138. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel A (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. The Journal of thoracic and cardiovascular surgery, 140(1), 169-73.
  139. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman C (2012). Improved survival in heart transplant patients living at high altitude. The Journal of thoracic and cardiovascular surgery, 143(3), 735-741.e1.
  140. Bowen ME, Liu X, Sundwall PM, Drakos SG, Li DY, Selzman CH, McKellar S (2018). Right ventricular involution: What can we learn from nature's model of compensated hypertrophy?. The Journal of thoracic and cardiovascular surgery, 155(5), 2024-2028.e1.
  141. Glotzbach JP, Sharma V, Tonna JE, Pettit JC, McKellar SH, Eckhauser AW, Varghese TK Jr, Selzman C (2018). Value-driven cardiac surgery: Achieving "perfect care" after coronary artery bypass grafting. The Journal of thoracic and cardiovascular surgery, 156(4), 1436-1448.e2.
  142. Sharma V, DeShazo RA, Skidmore CR, Glotzbach JP, Koliopoulou A, Javan H, McKellar SH, Powell DL, Selzman C (2020). Surgical explantation of atrial septal closure devices for refractory nickel allergy symptoms. The Journal of thoracic and cardiovascular surgery, 160(2), 502-509.e1.
  143. Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG, Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J, Schueler S, D'Alessandro D (2020). American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. The Journal of thoracic and cardiovascular surgery, 159(3), 865-896.
  144. Gaynor JS, Monnet E, Selzman C, Parker D, Kaufman L, Bryant HU, Mallinckrodt C, Wrigley R, Whitehill T, Turner A (2000). The effect of raloxifene on coronary arteries in aged ovariectomized ewes. Journal of veterinary pharmacology and therapeutics, 23(3), 175-9.
  145. Gaynor JS, Monnet E, Selzman C, Parker D, Kaufman L, Bryant HU, Mallinckrodt C, Wrigley R, Whitehill T, Turner A (2000). The effect of raloxifene on coronary arteries in aged ovariectomized ewes. Journal of veterinary pharmacology and therapeutics, 23, 175-179.
  146. Krupski WC, Selzman CH, Floridia R, Strecker PK, Nehler MR, Whitehill T (1998). Contemporary management of isolated iliac aneurysms. Journal of vascular surgery, 28(1), 1-11; discussion 11-3.
  147. Riesenman PJ, Farber MA, Mauro MA, Selzman CH, Feins R (2007). Aortoesophageal fistula after thoracic endografting and transthoracic embolization. Journal of vascular surgery, 46(4), 789-91.
  148. Riesenman PJ, Farber MA, Mauro MA, Selzman CH, Feins R (2007). Aortoesophageal fistula after thoracic endovascular aortic repair and transthoracic embolization. Journal of vascular surgery, 46(4), 789-91.
  149. Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ, Acker MA, Selzman CH, Soltesz EG, Kern JA, Maltais S, Charbonneau E, Pan S, Marks ME, Moquete EG, O'Sullivan KL, Taddei-Peters WC, McGowan LK, Green C, Rose EA, Jeffries N, Parides MK, Weisel RD, Miller MA, Hung J, O'Gara PT, Moskowitz AJ, Gelijns AC, Bagiella E, Milano CA, Cardiothoracic Surgical Trials Network (2019). Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial. JAMA, 321(12), 1176-1186.
  150. Witman MA, Garten RS, Gifford JR, Jonathan Groot H, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson R (2016). Peripheral Vascular Dysfunction Following Left Ventricular Assist Device Implantation: Insight from Passive Leg Movement: 706 Board #22 June 1, 3: 30 PM - 5: 00 PM. Medicine and science in sports and exercise, 48(5 Suppl 1), 189.
  151. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, STICH Hypothesis 2 Investigator (2009). Coronary bypass surgery with or without surgical ventricular reconstruction. The New England journal of medicine, 360(17), 1705-17.
  152. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang D (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Sciences of the United States of America, 105(6), 2111-6.
  153. Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, Baldwin AS, Wang DZ, Selzman C (2008). Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression. Proceedings of the National Academy of Sciences of the United States of America, 105(9), 3362-7.
  154. Warshauer DM, Archer RK, Selzman CH, Tmaddon HS, Mauro M (2007). Aortic pseudoaneurysm from penetrating superior vena cava stent. Radiology, 234(3), 901-4.
  155. Warshauer DM, Archer RK, Selzman CH, Tamaddon HS, Mauro M (2007). Case 115: aortic pseudoaneurysm from penetrating superior vena cava stent. Radiology, 243(3), 901-4.
  156. Krupski WC, Selzman CH, Whitehill T (1997). Unusal causes of mesenteric ischemia. The Surgical clinics of North America, 77(2), 471-502.
  157. Krupski WC, Selzman CH, Whitehill T (1997). Unusual causes of mesenteric ischemia. The Surgical clinics of North America, 77(2), 471-502.
  158. Selzman CH, Shames BD, Whitehill TA, Harken AH, McIntyre RC J (1998). Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation. Surgery, 124(2), 318-26; discussion 326-7.
  159. Zimmerman MA, Selzman CH, Harken A (1999). Surgical implications of therapeutic angiogenesis. Surgery, 125(3), 243-9.
  160. Cain BS, Meldrum DR, Selzman CH, Cleveland JC Jr, Meng X, Sheridan BC, Banerjee A, Harken A (1997). Surgical implications of vascular endothelial physiology. Surgery, 122(3), 516-26.
  161. Yamashita K, Hu N, Ranjan R, Selzman CH, Dosdall D (2019). Clinical Risk Factors for Postoperative Atrial Fibrillation among Patients after Cardiac Surgery. The Thoracic and cardiovascular surgeon, 67(2), 107-116.
  162. Selzman CH, Bhati RS, Sheridan BC, Stansfield WS, Mill M (2006). Surgical therapy for heart failure. Journal of the American College of Surgeons, 203(2), 226-39.
  163. Selzman CH, Bhati RS, Sheridan BC, Stansfield WE, Mill M (2006). Surgical therapy for heart failure. Journal of the American College of Surgeons, 203(2), 226-39; quiz A59-60.
  164. Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, Meng X, Harken AH, McIntyre RC J (1998). Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock (Augusta, Ga.), 10(6), 389-94.
  165. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC Jr, Harken A (1998). Therapeutic implications of interleukin-10 in surgical disease. Shock (Augusta, Ga.), 10(5), 309-18.
  166. Shames BD, Zallen GS, McIntryre RC Jr, Bensard DD, Pulido EJ, Miller SA, Pomerantz BJ, Selzman CH, Meng X, Harken A (2000). Chemokines as mediators of diseases related to surgical conditions. Shock (Augusta, Ga.), 14(1), 1-7.
  167. Shames BD, Zallen GS, McIntyre RC Jr, Bensard DD, Pulido EJ, Miller SA, Pomerantz BJ, Selzman CH, Meng X, Harken A (2000). Chemokines as mediators of diseases related to surgical conditions. Shock (Augusta, Ga.), 14(1), 1-7.
  168. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC Jr, Harken A (1998). Therapeutic implications of interleukin-10 in surgical disease. Shock (Augusta, Ga.), 10(5), 309-18.
  169. Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, Epelman S, Kreisel D, Liu Y, Itoh A, Shankar TS, Selzman CH, Drakos SG, Lavine K (2018). The human heart contains distinct macrophage subsets with divergent origins and functions. Nature medicine, 24(8), 1234-1245.
  170. Stehlik J, Rodriguez-Correa C, Spertus JA, Biber J, Nativi-Nicolau J, Zickmund S, Steinberg BA, Peritz DC, Walker A, Hess J, Drakos SG, Kfoury AG, Fang JC, Selzman CH, Hess (2017). Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study. Journal of cardiac failure, 23(11), 813-816.
  171. Zimmerman MA, Selzman CH, Reznikov LL, Raeburn CD, Barsness K, McIntyre RC Jr, Hamiel CR, Harken A (2002). Interleukin-11 attenuates human vascular smooth muscle cell proliferation. American journal of physiology. Heart and circulatory physiology, 283(1), H175-80.
  172. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee (2002). Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. American journal of physiology. Heart and circulatory physiology, 283(4), H1455-61.
  173. Moss NC, Stansfield WE, Willis MS, Tang RH, Selzman C (2007). IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. American journal of physiology. Heart and circulatory physiology, 293(4), H2248-53.
  174. Stansfield WE, Tang RH, Moss NC, Baldwin AS, Willis MS, Selzman C (2008). Proteasome inhibition promotes regression of left ventricular hypertrophy. American journal of physiology. Heart and circulatory physiology, 294(2), H645-50.
  175. Willis MS, Rojas M, Li L, Selzman CH, Tang RH, Stansfield WE, Rodriguez JE, Glass DJ, Patterson (2009). Muscle ring finger 1 mediates cardiac atrophy in vivo. American journal of physiology. Heart and circulatory physiology, 296(4), H997-H1006.
  176. Zhang XQ, Tang R, Li L, Szucsik A, Javan H, Saegusa N, Spitzer KW, Selzman C (2013). Cardiomyocyte-specific p65 NF-¿B deletion protects the injured heart by preservation of calcium handling. American journal of physiology. Heart and circulatory physiology, 305(7), H1089-97.
  177. Pepin ME, Drakos S, Ha CM, Tristani-Firouzi M, Selzman CH, Fang JC, Wende AR, Wever-Pinzon (2019). DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. American journal of physiology. Heart and circulatory physiology, 317(4), H674-H684.
  178. Reznikov LL, Shames BD, Barton HA, Selzman CH, Fantuzzi G, Kim SH, Johnson SM, Dinarello C (2000). Interleukin-1beta deficiency results in reduced NF-kappaB levels in pregnant mice. American journal of physiology. Regulatory, integrative and comparative physiology, 278(1), R263-70.
  179. Pulido EJ, Shames BD, Fullerton DA, Sheridan BC, Selzman CH, Gamboni-Robertson F, Bensard DD, McIntyre RC J (2000). Differential inducible nitric oxide synthase expression in systemic and pulmonary vessels after endotoxin. American journal of physiology. Regulatory, integrative and comparative physiology, 278(5), R1232-9.
  180. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken A (2002). Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury. American journal of physiology. Regulatory, integrative and comparative physiology, 283(2), R505-12.
  181. Zimmerman MA, Reznikov LL, Sorensen AC, Selzman C (2003). Relative contribution of the TNF-alpha receptors to murine intimal hyperplasia. American journal of physiology. Regulatory, integrative and comparative physiology, 284(5), R1213-8.
  182. Hydren JR, Gifford JR, Jarrett CL, Park SH, Shields KL, Broxterman RM, Kithas AC, Bisconti AV, Thurston TS, Ratchford SM, Wray DW, Stehlik J, Selzman CH, Drakos SG, Richardson R (2021). Vascular function in continuous-flow left ventricular assist device recipients: effect of a single pulsatility treatment session. American journal of physiology. Regulatory, integrative and comparative physiology, 320(4), R425-R437.
  183. Frey C, Koliopoulou AG, Montenont E, Tolley ND, Javan H, McKellar SH, Drakos SG, Selzman CH, Rondina M (2020). Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading. Platelets, 31(7), 952-959.
  184. Pires KM, Torres NS, Buffolo M, Gunville R, Schaaf C, Davis K, Selzman CH, Gottlieb RA, Boudina (2019). Suppression of Cardiac Autophagy by Hyperinsulinemia in Insulin Receptor-Deficient Hearts Is Mediated by Insulin-Like Growth Factor Receptor Signaling. Antioxidants & redox signaling, 31(6), 444-457.
  185. Selzman C (2001). Current approaches to therapy for vascular injury. Expert opinion on pharmacotherapy, 2(5), 753-64.
  186. Zimmerman MA, Albright TN, Raeburn CD, Selzman C (2002). Vasopressin in cardiovascular patients: therapeutic implication. Expert opinion on pharmacotherapy, 3(5), 505-12.
  187. Zimmerman MA, Albright TN, Raeburn CD, Selzman C (2002). Vasopressin in cardiovascular patients: therapeutic implications. Expert opinion on pharmacotherapy, 3(5), 505-12.
  188. Selzman C (2001). Current approaches to therapy for vascular injury. Expert opinion on pharmacotherapy, 2(5), 753-64.
  189. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. American journal of transplantation, 11(12), 2755-61.
  190. Pathak A, Zhao R, Monroe DM, Roberts HR, Sheridan BC, Selzman CH, Stouffer G (2006). Thrombin generation in vascular tissue. Journal of thrombosis and haemostasis, 4(1), 60-7.
  191. Taleb I, Wever-Pinzon J, Wang W, Koliopoulou A, Dranow E, Yu T, Yin L, McKellar SH, Stehlik J, Fang JC, Wever-Pinzon O, Selzman CH, Drakos S (2020). Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. Heart, lung & circulation, 29(8), 1226-1233.
  192. Patel AN, Selzman CH, Kumpati GS, McKellar SH, Bull D (2016). Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. Journal of cardiothoracic surgery, 11(1), 62.
  193. Zhang X, Javan H, Li L, Szucsik A, Zhang R, Deng Y, Selzman C (2013). A modified murine model for the study of reverse cardiac remodelling. Experimental and clinical cardiology, 18(2), e115-7.
  194. Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips J (2021). A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC research notes, 14(1), 32.
  195. Tonna JE, McKellar SH, Selzman CH, Drakos S, Koliopoulou AG, Taleb I, Stoddard GJ, Stehlik J, Welt FGP, Fair JF 3rd, Stoddard K, Youngquist S (2020). Exploratory analysis of myocardial function after extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation. BMC research notes, 13(1), 137.
  196. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circulation. Heart failure, 6(3), 517-26.
  197. Javan H, Szucsik AM, Li L, Schaaf CL, Salama ME, Selzman C (2015). Cardiomyocyte p65 nuclear factor-¿B is necessary for compensatory adaptation to pressure overload. Circulation. Heart failure, 8(1), 109-18.
  198. Stehlik J, Estep JD, Selzman CH, Rogers JG, Spertus JA, Shah KB, Chuang J, Farrar DJ, Starling RC, ROADMAP Study Investigators (2017). Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management). Circulation. Heart failure, 10(6),
  199. Uriel N, Burkhoff D, Rich JD, Drakos SG, Teuteberg JJ, Imamura T, Rodgers D, Raikhelkar J, Vorovich EE, Selzman CH, Kim G, Sayer (2019). Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circulation. Heart failure, 12(4), e006067.
  200. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon (2018). Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circulation. Heart failure, 11(11), e005267.
  201. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik (2018). Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circulation. Heart failure, 11(8), e004759.
  202. Zuñiga Cisneros J, Stehlik J, Selzman CH, Drakos SG, McKellar SH, Wever-Pinzon (2018). Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation. Circulation. Heart failure, 11(3), e004378.
  203. Symons JD, Deeter L, Deeter N, Bonn T, Cho JM, Ferrin P, McCreath L, Diakos NA, Taleb I, Alharethi R, McKellar S, Wever-Pinzon O, Navankasattusas S, Selzman CH, Fang JC, Drakos S (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circulation. Heart failure, 12(8), e006085.
  204. Shah P, Psotka M, Taleb I, Alharethi R, Shams MA, Wever-Pinzon O, Yin M, Latta F, Stehlik J, Fang JC, Diao G, Singh R, Ijaz N, Kyriakopoulos CP, Zhu W, May CW, Cooper LB, Desai SS, Selzman CH, Kfoury AG, Drakos S (2021). Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages. Circulation. Heart failure, 14(5), e007991.
  205. Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos S (2018). Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study. Circulation. Cardiovascular imaging, 11(4), e007117.
  206. DeBoard ZM, Varghese TK Jr, Doty JR, Selzman C (2019). Cardiothoracic Surgery Residency Training in Surgical Ablation for Atrial Fibrillation. Journal of atrial fibrillation, 12(1), 2195.
  207. Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman C (2021). Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ open, 11(2), e045162.
  208. Wohlfahrt P, Zickmund SL, Slager S, Allen LA, Nicolau JN, Kfoury AG, Felker GM, Conte J, Flint K, DeVore AD, Selzman CH, Hess R, Spertus JA, Stehlik (2020). Provider Perspectives on the Feasibility and Utility of Routine Patient-Reported Outcomes Assessment in Heart Failure: A Qualitative Analysis. Journal of the American Heart Association, 9(2), e013047.
  209. Tonna JE, Selzman CH, Girotra S, Presson AP, Thiagarajan RR, Becker LB, Zhang C, Keenan HT, American Heart Association's Get With the Guidelines'Resuscitation Investigators (2020). Patient and Institutional Characteristics Influence the Decision to Use Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest. Journal of the American Heart Association, 9(9), e015522.
  210. Diakos NA, Taleb I, Kyriakopoulos CP, Shah KS, Javan H, Richins TJ, Yin MY, Yen CG, Dranow E, Bonios MJ, Alharethi R, Koliopoulou AG, Taleb M, Fang JC, Selzman CH, Stellos K, Drakos S (2021). Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support. Journal of the American Heart Association, 10(20), e020238.
  211. Carson P, Wertheimer J, Miller A, O'Connor CM, Pina IL, Selzman C, Sueta C, She L, Greene D, Lee KL, Jones RH, Velazquez E (2013). Surgical Treatment for Ischemic Heart Failure (STICH) Trial: Mode of Death Results.LID - 10.1016/j.jchf.2013.04.012 [doi]. JACC. Heart failure, 1(5),
  212. Carson P, Wertheimer J, Miller A, O'Connor CM, Pina IL, Selzman C, Sueta C, She L, Greene D, Lee KL, Jones RH, Velazquez EJ, STICH Investigators (2013). The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. JACC. Heart failure, 1(5), 400-8.
  213. Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson R (2015). Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility. JACC. Heart failure, 3(9), 703-11.
  214. Al-Sarie M, Rauf A, Kfoury AG, Catino A, Wever-Pinzon J, Bonios M, Horne BD, Diakos NA, Wever-Pinzon O, McKellar SH, Kelkhoff A, McCreath L, Fang J, Stehlik J, Selzman CH, Drakos S (2016). Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow. JACC. Heart failure, 4(7), 570-576.
  215. Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, Bruckner BA, Lee S, Long JW, Selzman CH, Kasirajan V, Haas DC, Boyle AJ, Chuang J, Farrar DJ, Rogers JG, ROADMAP Study Investigators (2017). Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results. JACC. Heart failure, 5(7), 518-527.
  216. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon (2020). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC. Heart failure, 8(4), 302-312.
  217. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik (2021). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA cardiology, 6(8), 957-962.
  218. Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Miller DV, Park SY, Richardson RS, Deberardinis R, Cox JE, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos S (2016). Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning. JACC. Basic to translational science, 1(6), 432-444.
  219. Lyu Y, Verma VK, Lee Y, Taleb I, Badolia R, Shankar TS, Kyriakopoulos CP, Selzman CH, Caine W, Alharethi R, Navankasattusas S, Seidel T, Drakos SG, Sachse F (2021). Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart. NPJ aging and mechanisms of disease, 7(1), 16.
  220. Cain BS, Meldrum DR, Selzman CH, Cleveland JC Jr, Meng X, Sheridan BC, Banerjee A, Harken AH (1997). Surgical implication of vascular endothelial biology. Surgery (Oxford, Oxfordshire), 122(3), 516-26.
  221. Zimmerman MA, Selzman CH, Harken A (1999). Surgical implications of therapeutic angiogenesis. Surgery (Oxford, Oxfordshire), 125(3), 243-9.
  222. Topkara VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, Takeda K, Takayama H, Selzman CH, Naka Y, Burkhoff D, Stehlik J, Farr MA, Fang JC, Uriel N, Drakos S (2022). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. Journal of the American College of Cardiology, 79(9), 900-913.
  223. Sommakia S, Almaw NH, Lee SH, Ramadurai DKA, Taleb I, Kyriakopoulos CP, Stubben CJ, Ling J, Campbell RA, Alharethi RA, Caine WT, Navankasattusas S, Hoareau GL, Abraham AE, Fang JC, Selzman CH, Drakos SG, Chaudhuri (2021). FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure. Circulation. Heart failure, 15(3), CIRCHEARTFAILURE121008910.
  224. Tonna JE, Selzman CH, Girotra S, Presson AP, Thiagarajan RR, Becker LB, Zhang C, Rycus P, Keenan HT, American Heart Association Get With the Guidelines'Resuscitation Investigators (2022). Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA) Mortality Prediction Score and External Validation. JACC. Cardiovascular interventions, 15(3), 237-247.
  225. Wilson TW, Horns JJ, Sharma V, Goodwin ML, Kagawa H, Pereira SJ, McKellar SH, Selzman CH, Glotzbach J (2022). Minimally Invasive versus Full Sternotomy SAVR in the Era of TAVR: An Institutional Review. Journal of clinical medicine, 11(3),
  226. Gelhard S, O'Brien L, Vincenti S, Smego DR, Hobbs R, Varghese TK Jr, Selzman CH, Pereira S (2023). Disparities in Gender and Diversity Representation Among Surgical Subspecialties: Are we Losing Momentum?. The Journal of surgical research, 293, 413-419.
  227. Kagawa H, Stringham J, Selzman C, Goodwin M, Frye L, Raman S, Cahill B, Morrell (2023). Case Report of Needle Disruption of the Retroperitoneal Lymph Nodes for Refractory Chylothorax After Double Lung Transplantation. Transplantation proceedings, 55(8), 1981-1983.
  228. Kagawa H, Goodwin M, Stehlik J, Campsen J, Baker T, Selzman C (2023). A Case Report of Triple Organ Transplantation From a Donor After Circulatory Death Using Thoraco-Abdominal Normothermic Regional Perfusion. Transplantation proceedings, 55(8), 1883-1887.
  229. Hirahara AM, Khan MS, Ishidoya Y, Smego D, Roman O, Ranjan R, Krueger L, Hoareau G, Selzman CH, Dosdall D (2023). Canine Model of Ischemia-Induced Ventricular Tachycardia. The Journal of surgical research, 293, 196-203.
  230. Glotzbach JP, Hanson HA, Tonna JE, Horns JJ, McCarty Allen C, Presson AP, Griffin CL, Zak M, Sharma V, Tristani-Firouzi M, Selzman C (2023). Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database. Circulation, 148(8), 637-647.
  231. Kyriakopoulos CP, Horne BD, Sideris K, Taleb I, Griffin RJ, Sheffield E, Alharethi R, Hanff TC, Stehlik J, Selzman CH, Drakos S (2023). Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support. The Journal of heart and lung transplantation, 42(7), 853-858.
  232. Gatsiou A, Tual-Chalot S, Napoli M, Ortega-Gomez A, Regen T, Badolia R, Cesarini V, Garcia-Gonzalez C, Chevre R, Ciliberti G, Silvestre-Roig C, Martini M, Hoffmann J, Hamouche R, Visker JR, Diakos N, Wietelmann A, Silvestris DA, Georgiopoulos G, Moshfegh A, Schneider A, Chen W, Guenther S, Backs J, Kwak S, Selzman CH, Stamatelopoulos K, Rose-John S, Trautwein C, Spyridopoulos I, Braun T, Waisman A, Gallo A, Drakos SG, Dimmeler S, Sperandio M, Soehnlein O, Stellos (2023). The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation. Immunity, 56(5), 979-997.e11.
  233. Hirahara AM, Khan MS, Gharbia OA, Lange M, Ishidoya Y, Smego D, Ranjan R, Stoddard GJ, Selzman CH, Dosdall D (2023). Antitachycardia pacing at the His bundle is safer than conventional right ventricular antitachycardia pacing in a canine myocardial ischemic injury model. Journal of cardiovascular electrophysiology, 34(5), 1249-1256.
  234. Palatinus JA, Valdez S, Taylor L, Whisenant C, Selzman CH, Drakos SG, Ranjan R, Hong T, Saffitz JE, Shaw R (2023). GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy. Circulation research, 132(6), 744-746.
  235. Hanff TC, Browne A, Dickey J, Gaines H, Harhay MO, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik (2023). Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients. The Journal of heart and lung transplantation, 42(3), 368-376.
  236. Khan MS, Smego D, Ishidoya Y, Hirahara AM, Offei E, Ruiz Castillo MS, Gharbia O, Li H, Palatinus JA, Krueger L, Hong T, Hoareau GL, Ranjan R, Selzman CH, Shaw RM, Dosdall D (2023). A canine model of chronic ischemic heart failure. American journal of physiology. Heart and circulatory physiology, 324(6), H751-H761.
  237. Browne A, Gaines H, Alharethi R, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J, Hanff T (2023). Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy Change. Journal of cardiac failure, 29(2), 220-224.
  238. Selzman CH, Feller ED, Walker JC, Sheridan BC, Silvestry SC, Daly RC, Anyanwu AC, Madigan D, Liu PY, Frazier OH, Jorde UP, Griffith B (2023). The Jarvik 2000 Left Ventricular Assist Device: Results of the United States Bridge to Transplant Trial. ASAIO journal (American Society for Artificial Internal Organs, 69(2), 174-182.
  239. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin (2023). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424.
  240. Vigneshwar NG, Masood MF, Vasic I, Krause M, Bartels K, Lucas MT, Bronsert M, Selzman CH, Thompson S, Rove JY, Reece TB, Cleveland JC, Pal JD, Fullerton DA, Aftab (2022). Venovenous extracorporeal membrane oxygenation support in patients with COVID-19 respiratory failure: A multicenter study. JTCVS open, 12, 211-220.
  241. Ciullo AL, Wall N, Taleb I, Koliopoulou A, Stoddard K, Drakos SG, Welt FG, Goodwin M, Van Dyk N, Kagawa H, McKellar SH, Selzman CH, Tonna J (2022). Effect of Portable, In-Hospital Extracorporeal Membrane Oxygenation on Clinical Outcomes. Journal of clinical medicine, 11(22),
  242. Wert L, Stewart GC, Mehra MR, Milwidsky A, Jorde UP, Goldstein DJ, Selzman CH, Stehlik J, Alshamdin FD, Khaliel FH, Gustafsson F, Boschi S, Loforte A, Ajello S, Scandroglio AM, Tu'anová Z, Netuka I, Schlöglhofer T, Zimpfer D, Zijderhand CF, Caliskan K, Dogan G, Schmitto JD, Maier S, Schibilsky D, Jawad K, Saeed D, Faerber G, Morshuis M, Hanuna M, Müller CS, Mulzer J, Kempfert J, Falk V, Potapov E (2022). A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device. The Journal of thoracic and cardiovascular surgery,
  243. Felker GM, Buttrick P, Rosenzweig A, Abel ED, Allen LA, Bristow M, Das S, DeVore AD, Drakos SG, Fang JC, Freedman JE, Hernandez AF, Li DY, McKinsey TA, Newton-Cheh C, Rogers JG, Shah RV, Shah SH, Stehlik J, Selzman C (2022). Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions. Journal of the American Heart Association, 11(18), e025517.
  244. Tonna JE, Selzman CH, Bartos JA, Presson AP, Ou Z, Jo Y, Becker L, Youngquist ST, Thiagarajan RR, Johnson MA, Rycus P, Keenan H (2022). The Association of Modifiable Postresuscitation Management and Annual Case Volume With Survival After Extracorporeal Cardiopulmonary Resuscitation. Critical care explorations, 4(7), e0733.
  245. Sadeh B, Ugolini S, Pinzon OW, Potapov EV, Selzman CH, Bader F, Zuckermann AO, Gomez-Mesa JE, Shah KS, Alharethi R, Morejon-Barragan P, Hanff T, Goldraich LA, Farrero M, MacDonald PS, Drakos S, Mehra MR, Stehlik (2022). Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey. Clinical transplantation, 36(7), e14733.
  246. Orkild BA, Zenger B, Iyer K, Rupp LC, Ibrahim MM, Khashani AG, Perez MD, Foote MD, Bergquist JA, Morris AK, Kim JJ, Steinberg BA, Selzman C, Ratcliffe MB, MacLeod RS, Elhabian S, Morgan A (2022). All Roads Lead to Rome: Diverse Etiologies of Tricuspid Regurgitation Create a Predictable Constellation of Right Ventricular Shape Changes. Frontiers in physiology, 13, 908552.
  247. Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS, Stehlik J, Chamogeorgakis T, McKellar SH, Koliopoulou A, Alharethi R, Kfoury AG, Bonios M, Adamopoulos S, Gilbert EM, Fang JC, Kirklin JK, Drakos S (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circulation. Heart failure, 15(6), e008706.
  248. Tonna JE, Selzman CH, Bartos JA, Presson AP, Ou Z, Jo Y, Becker LB, Youngquist ST, Thiagarajan RR, Austin Johnson M, Cho SM, Rycus P, Keenan H (2022). The association of modifiable mechanical ventilation settings, blood gas changes and survival on extracorporeal membrane oxygenation for cardiac arrest. Resuscitation, 174, 53-61.
  249. Glotzbach JP, Hanson HA, Tonna JE, Horns JJ, Allen CM, Presson AP, Griffin CL, Zak M, Sharma V, Tristani-Firouzi M, Selzman C (2023). Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database. Circulation, 148(8),
  250. Goodwin ML, Nickel IC, Li H, Kagawa H, Kyriakopoulos CP, Hanff TC, Stehlik J, Drakos SG, Selzman C (2025). Direct procurement with machine perfusion and normothermic regional perfusion in donation after circulatory death heart transplantation. The Journal of thoracic and cardiovascular surgery, 170(1), 256-265.e6.
  251. Gelhard S, Asban A, Selzman C (2024). Giant Coronary Artery Aneurysms With Coronary Sinus Fistula: Forget the Distal Bypass. Annals of thoracic surgery short reports, 3(2), 424-426.
  252. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Tseliou E, Aadland J, Baird AS, Bonios MJ, Nelson M, Dranow E, Goodwin ML, Hanff TC, Carter S, Selzman CH, Stehlik J, Wever-Pinzon O, Ramakrishna S, Tumarkin E, Drakos S (2025). Left Atrial Reverse Remodeling in Patients Supported With Durable Left Ventricular Assist Devices and Clinical Implications. Circulation. Heart failure, 18(7), e012807.
  253. Xie Y, Tucciarone L, Farah EN, Chang L, Yang Q, Shankar TS, Elison W, Tran S, Djulamsah J, Lie A, Loe T, Holman AR, Corban S, Buchanan J, Mamde S, Zhou H, Elgamal RM, Tseliou E, Huang V, Wang Z, Chiu J, Melton R, Griffin E, Zhang Q, Lucero J, Navankasattusas S, Li D, Seng C, Destici E, Selzman CH, D'Antonio-Chronowska A, Wang T, Wang A, Drakos SG, Gaulton KJ, Ren B, Chi N (2025). Single cell multiomics and 3D genome architecture reveal novel pathways of human heart failure.
  254. Schäfer M, Selzman CH, DiChiacchio L, Heiler JC, Ramakrishna S, Tumarkin E, Hill B, Kagawa H, Contreras N, Raman S, Frye L, Cahill B, Morrell M, Goodwin M (2025). Reduced left atrial compliance exacerbates primary graft dysfunction after lung transplantation. The Journal of thoracic and cardiovascular surgery,
  255. Valdez SE, Taylor LA, Selzman CH, Drakos SG, Shaw RM, Palatinus J (2025). Left Ventricular Unloading With Assist Device Implantation Increases GJA1-20k Expression in Patients With Arrhythmogenic Cardiomyopathy. Circulation. Heart failure, 18(5), e012174.
  256. Schäfer M, Glotzbach JP, Sharma V, Tandar A, Welt FG, L Goodwin M, Smego D, Selzman CH, Pereira S (2025). Aortic shape and diameter variations are predictive of short-term complications in transcatheter aortic valve replacement. The international journal of cardiovascular imaging, 41(5), 955-965.
  257. Sideris K, Zhang M, Wohlfahrt P, Siu AF, Shen J, Carter S, Kyriakopoulos CP, Taleb I, Wever-Pinzon O, Shah K, Selzman CH, Rodriguez-Correa C, Kapelios C, Brinker L, Alharethi R, Hess R, Drakos SG, Steinberg BA, Fang JC, Kfoury AG, Melenovsky V, Greene T, Spertus JA, Stehlik (2025). Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure. Journal of cardiac failure, 31(5), 761-770.
  258. Scott M, Kyriakopoulos CP, Sheffield E, Krauspe E, Sideris K, Taleb I, Maneta E, Tseliou E, Selko S, Hamouche R, Aadland J, Carter SJ, Jones TL, Ou Z, Presson AP, Selzman CH, Tonna JE, Hanff TC, Drakos S (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. The Canadian journal of cardiology, 31(5), 761-770.
  259. Khan MS, Smego D, Li J, Ishidoya Y, Offei E, Ruiz Castillo MS, Hirahara AM, Balmaceda P, Hunter J, Athavale A, Revelo MP, Palatinus JA, Selzman CH, Ranjan R, Hong T, Dosdall DJ, Shaw R (2025). AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model. Communications medicine, 5(1), 93.
  260. Gustafsson F, Uriel N, Netuka I, Katz JN, Pagani FD, Connors JM, Jorde UP, Zimpfer D, Pya Y, Conway J, Anyanwu A, Scandroglio AM, Sulemanjee N, Atluri P, Keebler M, Selzman CH, Alexis JD, Hayward C, Henderson J, Dirckx N, Gazzola C, Mehra MR, ARIES Investigator (2025). Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial. JAMA cardiology, 10(3), 235-242.
  261. Bia R, Mitchell G, Javan H, Nickel I, Pierce J, Selzman CH, Franklin (2025). Proteomic Characterization of Cardioprotective Human Acellular Amniotic Fluid. ACS omega, 10(7), 6918-6926.
  262. Kyriakopoulos CP, Taleb I, Sideris K, Maneta E, Hamouche R, Tseliou E, Krauspe E, Selko S, Carter S, Jones TL, Zhang C, Presson AP, Dranow E, Geer L, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2025). Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a Hub. Journal of the American Heart Association, 14(4), e035464.
  263. Derks W, Rode J, Collin S, Rost F, Heinke P, Hariharan A, Pickel L, Simonova I, Lázár E, Graham E, Jashari R, Andrä M, Jeppsson A, Salehpour M, Alkass K, Druid H, Kyriakopoulos CP, Taleb I, Shankar TS, Selzman CH, Sadek H, Jovinge S, Brusch L, Frisén J, Drakos S, Bergmann (2025). A Latent Cardiomyocyte Regeneration Potential in Human Heart Disease. Circulation, 151(3), 245-256.
  264. Li J, Balmaceda P, Ha T, Visker JR, Maalouf N, Kwan E, Hoareau GL, Accad M, Ranjan R, Selzman CH, Drakos SG, Shaw RM, Hong (2024). Cardiac bridging integrator 1 gene therapy rescues chronic non-ischemic heart failure in minipigs. NPJ Regenerative medicine, 9(1), 36.
  265. Brant-Zawadzki G, Hoareau GL, Stoecklein HH, Levin N, Selzman CH, Ciullo A, Tonna J, Kelly C, Jones J, Youngquist ST, Johnson M (2024). Successful Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) deployment by emergency medicine physicians for refractory non-traumatic cardiac arrest. Resuscitation plus, 20, 100784.
  266. Yin MY, Maneta E, Kyriakopoulos CP, Michaels AT, Genovese LD, Indaram MB, Wever-Pinzon O, Singh R, Tseliou E, Taleb I, Nemeh HW, Alharethi R, Tang DG, Goldstein J, Hanff TC, Selzman CH, Cowger J, Kanwar M, Shah P, Drakos S (2024). Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices. ASAIO journal (American Society for Artificial Internal Organs, 70(12), 1060-1066.
  267. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K, Tseliou E, Shah KS, Tonna JE, Dranow E, Jones TL, Carter SJ, Fang JC, Stehlik J, Ohsfeldt RL, Selzman CH, Hanff TC, Drakos S (2024). Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circulation. Heart failure, 17(11), e011709.
  268. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Hamouche R, Tseliou E, Zhang C, Presson AP, Dranow E, Shah KS, Jones TL, Fang JC, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2024). Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic Shock. Circulation. Heart failure, 17(9), e011358.
  269. Chavez MA, Anderson M, Kyriakopoulos CP, Scott M, Dranow E, Maneta E, Hamouche R, Taleb I, Leon J, Kogelschatz B, Goldstein J, Billia F, Baran DA, Tehrani B, Goodwin M, Selzman CH, Tonna JE, Fang JC, Drakos SG, Hanff T (2024). Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circulation. Heart failure, 17(9), e011827.
  270. Kyriakopoulos CP, Taleb I, Tseliou E, Sideris K, Hamouche R, Maneta E, Nelson M, Krauspe E, Selko S, Visker JR, Dranow E, Goodwin ML, Alharethi R, Wever-Pinzon O, Fang JC, Stehlik J, Selzman CH, Hanff TC, Drakos S (2024). Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support. Journal of the American Heart Association, 13(14), e032936.
  271. Kyriakopoulos CP, Selzman CH, Giannouchos TV, Mylavarapu R, Sideris K, Elmer A, Vance N, Hanff TC, Kagawa H, Stehlik J, Drakos SG, Goodwin M (2024). Hospital Readmissions in Patients Supported with Durable Centrifugal-Flow Left Ventricular Assist Devices. Journal of clinical medicine, 13(10),
  272. Sideris K, Lázár-Molnár E, Kyriakopoulos CP, Taleb I, Hurst D, Ugolini S, Selzman CH, Brinker L, Drakos SG, Tonna JE, Geer L, Goodwin ML, Wever-Pinzon O, Hanff TC, Fang JC, Carter S, Stehlik (2024). Bridge-to-transplant temporary mechanical circulatory support and risk of allosensitization. Clinical transplantation, 38(5), e15330.
  273. Khan MS, Kyriakopoulos CP, Taleb I, Dranow E, Scott M, Ranjan R, Yin M, Tseliou E, Alharethi R, Caine W, Shaw RM, Selzman CH, Drakos SG, Dosdall D (2022). Baseline QRS duration associates with cardiac recovery in patients with continuous-flow left ventricular assist device implantation. American heart journal plus, 22, 100211.
  274. Balderas E, Lee SHJ, Shankar TS, Yin X, Balynas AM, Kyriakopoulos CP, Selzman CH, Drakos SG, Chaudhuri (2023). Mitochondria possess a large, non-selective ionic current that is enhanced during cardiac injury. bioRxiv,
  275. Derks W, Rode J, Collin S, Rost F, Heinke P, Hariharan A, Pickel L, Simonova I, Lázár E, Graham E, Jashari R, Andrä M, Jeppsson A, Salehpour M, Alkass K, Druid H, Kyriakopoulos CP, Taleb I, Shankar TS, Selzman CH, Sadek H, Jovinge S, Brusch L, Frisén J, Drakos S, Bergmann (2023). A latent cardiomyocyte regeneration potential in human heart disease. bioRxiv,
  276. Dichiacchio L, Heiler J, Kagawa H, Selzman CH, Goodwin M (2024). Minimally Invasive Direct Aortic Implantation of Impella 5.5 As Bridge to Transplant: A Case Report. Transplantation proceedings, 56(1), 145-147.
  277. Tonna JE, Pierce J, Brintz BJ, Bardsley T, Hatton N, Lewis G, Phillips JD, Skidmore CR, Selzman C (2023). A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19. BMC infectious diseases, 23(1), 864.
  278. Jentzer JC, Drakos SG, Selzman CH, Owyang C, Teran F, Tonna J (2024). Timing of Initiation of Extracorporeal Membrane Oxygenation Support and Outcomes Among Patients With Cardiogenic Shock. Journal of the American Heart Association, 13(3), e032288.
  279. Hockstein MA, Horns JJ, Hanff T, Taleb I, Selzman C, Drakos S, Nelson R, Tonna J (2026). Hospital Costs Associated With Mechanical Left Ventricular Unloading Devices During VA ECMO for Adult Cardiogenic Shock. Artificial organs,
  280. Schäfer M, Heiler JC, DiChiacchio L, Ramakrishna S, Tumarkin E, Hill B, Scott A, Raman S, Frye L, Cahill B, Morrell M, Kagawa H, Contreras N, Selzman CH, Goodwin M (2026). The Preoperative Role of Right-Sided Heart Function in Primary Graft Dysfunction After Bilateral Lung Transplantation. The Annals of thoracic surgery,
  281. Katz JN, Connors JM, Pagani FD, Jorde UP, Gustafsson F, Uriel N, Netuka I, Byku M, Anyanwu A, Keebler M, Nathan S, Selzman CH, Alexis JD, Sulemanjee N, Atluri P, D'Allesandro D, Porter S, Lee FS, Mehra MR, ARIES Investigator (2026). Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial. JACC. Heart failure, 14(3), 102769.
  282. Kyriakopoulos CP, Sideris K, Kyriakoulis I, Taleb I, Maneta E, Zhang C, Tseliou E, Carter S, Florido R, Welt FG, Stehlik J, Selzman CH, Fang JC, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2026). Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock. European heart journal open, 6(1), oeag015.
  283. Carley AN, Maurya SK, Maurya CK, Wang Y, Webb A, Challa AA, Gromova T, Vondriska TM, Zhang Z, Zhu H, Heydemann A, Bedi KC Jr, Kyriakopoulos CP, Selzman CH, Drakos SG, Margulies KB, Lewandowski E (2026). CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress That Enables Rescue by Gene Transfer. Circulation research, 138(2), e327403.
  284. Hamouche R, Tatum SM, Dranow E, Maschek JA, Kyriakopoulos CP, Shankar TS, Visker JR, Ling J, Sideris K, Selzman CH, Kfoury AG, Stehlik J, Alharethi R, Fang JC, Hong T, Navankasattusas S, Rondina MT, Holland WL, Summers SA, Drakos SG, Tseliou (2026). The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support. JACC. Basic to translational science, 11(1), 101435.
  285. Mitchell G, Javan H, Nickel I, Valdez S, Palatinus JA, Szulik M, Eberhardt D, Franklin S, Chaudhuri D, Skliar M, Ripoll CV, Pierce J, Selzman C (2025). Intravenous acellular human amniotic fluid prevents ischemic cardiac remodeling. Scientific reports, 15(1), 44725.
  286. Bansal N, Maneta E, Zelnick L, Kyriakopoulos CP, Beddhu S, Hartsell S, Stempien-Otero A, Welt F, Tseliou E, Hanff T, Nelson M, Sideris K, Kyriakoulis I, Goldstein J, Mendenhall T, Deol A, Alharethi R, Selzman C, Drakos (2025). Association of Kidney Function With Myocardial Recovery and Adverse Events Following Left Ventricular Assist Device Circulatory Support. Journal of the American Heart Association, 14(24), e043498.
  287. Scott M, Kyriakopoulos CP, Sheffield E, Krauspe E, Sideris K, Taleb I, Maneta E, Tseliou E, Selko S, Hamouche R, Aadland J, Carter SJ, Jones TL, Ou Z, Presson AP, Selzman CH, Tonna JE, Hanff TC, Drakos S (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. The Canadian journal of cardiology, 41(10), 2053-2063.
  288. Kagawa H, Silvester B, Smego D, Sharma V, Goodwin M, Steely A, Glotzbach J, Pereira S, Selzman (2025). Surgical Therapy for Pulmonary Artery Aneurysm. Annals of thoracic surgery short reports, 3(3), 561-565.
  289. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K, Tseliou E, Shah KS, Tonna JE, Dranow E, Jones TL, Carter SJ, Fang JC, Stehlik J, Ohsfeldt RL, Selzman CH, Hanff TC, Drakos S (2024). Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circulation. Heart failure, 17(11), e011709.
  290. Perry AS, Amancherla K, Huang X, Lance ML, Farber-Eger E, Gajjar P, Amrute J, Stolze L, Zhao S, Sheng Q, Joynes CM, Peng Z, Tanaka T, Drakos SG, Lavine KJ, Selzman C, Visker JR, Shankar TS, Ferrucci L, Das S, Wilcox J, Patel RB, Kalhan R, Shah SJ, Walker KA, Wells Q, Tucker N, Nayor M, Shah RV, Khan S (2024). Clinical-transcriptional prioritization of the circulating proteome in human heart failure. Cell reports. Medicine, 5(9), 101704.
  291. Sideris K, Lázár-Molnár E, Kyriakopoulos CP, Taleb I, Hurst D, Ugolini S, Selzman CH, Brinker L, Drakos SG, Tonna JE, Geer L, Goodwin ML, Wever-Pinzon O, Hanff TC, Fang JC, Carter S, Stehlik (2024). Bridge-to-transplant temporary mechanical circulatory support and risk of allosensitization. Clinical transplantation, 38(5), e15330.

Review

  1. DiChiacchio L, Goodwin ML, Kagawa H, Griffiths E, Nickel IC, Stehlik J, Selzman C (2023). Heart Transplant and Donors After Circulatory Death: A Clinical-Preclinical Systematic Review. The Journal of surgical research, 292, 222-233.
  2. Kanwar MK, Selzman CH, Ton VK, Miera O, Cornwell WK 3rd, Antaki J, Drakos S, Shah (2022). Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support. The Journal of heart and lung transplantation, 41(10), 1324-1334.
  3. Tsarova K, Morgan AE, Melendres-Groves L, Ibrahim MM, Ma CL, Pan IZ, Hatton ND, Beck EM, Ferrel MN, Selzman CH, Ingram D, Alamri AK, Ratcliffe MB, Wilson BD, Ryan J (2022). Imaging in Pulmonary Vascular Disease-Understanding Right Ventricle-Pulmonary Artery Coupling. Comprehensive Physiology, 12(4), 3705-3730.
  4. Nickel I, Potapov E, Sun B, Zimpfer D, Koliopoulou A, Adachi I, Anyanwu A, Falk V, Atluri P, Faerber G, Goldstein D, Yarboro L, Slaughter MS, Milano C, Tsukashita M, D'Alessandro D, Silvestry S, Kirov H, Bommareddi S, Lanmüller P, Doenst T, Selzman C (2024). Deactivation of LVAD support for myocardial recovery-surgical perspectives. The Journal of heart and lung transplantation, 43(9), 1489-1500.
  5. Kyriakoulis I, Nickel I, Kanwar MK, Hanff TC, Stehlik J, Selzman CH, Drakos S (2026). International Utah Cardiac Recovery Symposium (U-CARS) 2025: Clinical Science Proceedings. Heart failure reviews, 31(1),
  6. Kagawa H, Contreras N, Goodwin M, Frye L, Raman S, Cahill B, Hachem R, Morrell M, Selzman C (2026). Targeting leukocytes, neutrophil extracellular traps and cytokines: A conceptual review to prevent primary graft dysfunction after lung transplantation. Transplantation reviews (Orlando, Fla.), 40(2), 100989.
  7. Nickel I, Mitchell G, Javan H, Pierce J, Ripoll CV, Selzman C (2025). Cardiovascular Therapeutic Applications of the Human Amnion: Membrane, Cells, and Beyond. Journal of cardiovascular pharmacology and therapeutics, 30, 10742484251380914.

Book Chapter

  1. Selzman C (2000). Pathogenesis of atherosclerosis. 229-232.
  2. Selzman C (2004). Mechanistic approaches to therapy for vascular injury. 1-34.
  3. Selzman CH, Cleveland J (2004). Perioperative cardiac evaluation. 4-7.
  4. Selzman C (2004). Pathogenesis of atherosclerosis. 255-258.
  5. Andersen NC, Selzman C (2008). Pathogenesis of atherosclerosis. 255-258.
  6. Stansfield WE, Koliopoulou A, Mckellar SH, Selzman C Mechanical Circulatory Support.

Case Report

  1. Wilder TJ, Sharma V, Koliopoulou A, McKellar SH, Selzman CH, Glotzbach J (2020). Rapid-deployment aortic valve replacement after aortic root replacement: A safe alternative to redo root replacement. Journal of cardiac surgery, 35(1), 222-225.
  2. Peritz DC, Linstroth L, Selzman CH, Gilbert E (2018). Left ventricular perforation after Impella® placement in a patient with cardiogenic shock. Catheterization and cardiovascular interventions, 91(5), 894-896.
  3. Levy LE, Brann A, DiChiacchio L, Leon J, Welt F, Kagawa H, Kemeyou L, Selzman C (2025). Antepartum Temporary Heart Pump Placement to Support Delivery and Bridge to Transplant. JACC. Case reports, 30(23), 104496.
  4. Kelly C, Stoecklein HH, Brant-Zawadzki G, Hoareau G, Daley J, Selzman C, Youngquist S, Johnson (2023). TEE guided REBOA deflation following ROSC for non-traumatic cardiac arrest. The American journal of emergency medicine, 63, 182.e5-182.e7.

Editorial

  1. Selzman C (2006). Invited commentary on "Improved mechanical reliability of the Heartmate XVE left ventricular assist device. The Annals of thoracic surgery, 82(4), 1418-1419.
  2. Selzman C (2008). Invited commentary on "Gene Transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits. The Annals of thoracic surgery, 85, 585-6.
  3. Selzman C (2009). Invited commentary on "Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection". The Annals of thoracic surgery, 87, 819.
  4. Selzman C (2010). Invited commentary on "Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease". The Annals of thoracic surgery, 90, 123.
  5. Selzman C (2011). Invited commentary on "Aortic valve cyclic stretch causes increased remodeling activitiy and enhanced serotonin receptor responsiveness". The Annals of thoracic surgery, 92, 153-54.
  6. Selzman C (2012). Invited commentary on "Should patients age 60 and older be bridged to transplant using a contiuous flow left ventricular assist device". The Annals of thoracic surgery, 94(6), 2024.
  7. Cahill BC, Raman SM, Selzman CH, Liou T (2013). Use of older donors for lung transplantation-you can't get there from here. The Journal of heart and lung transplantation, 32(8), 757-9.
  8. Selzman C (2006). NFkappaB decoys to prevent vein graft stenosis Invited Editorial on "inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model". Journal of molecular and cellular cardiology, 41(3), 410-2.
  9. Selzman C (2016). Let's get high. The Journal of thoracic and cardiovascular surgery, 152(1), 221-2.
  10. Goodwin ML, Selzman C (2021). Take a load off: Unloading and reperfusion. The Journal of thoracic and cardiovascular surgery, 161(6), 2046-2050.
  11. Glotzbach JP, Selzman C (2021). Commentary: Recalibrating the eyeball test. The Journal of thoracic and cardiovascular surgery, 161(6), 2106-2107.
  12. Goodwin ML, Selzman C (2021). Commentary: What the eye doesn't see and the mind doesn't know, doesn't exist. The Journal of thoracic and cardiovascular surgery, 164(6), 1931-1932.
  13. Selzman (2021). Commentary: Latent hypertrophic obstructive cardiomyopathy-(Un)clear and present danger. The Journal of thoracic and cardiovascular surgery,
  14. Griffin CL, Sharma V, Sarfati MR, Smith BK, Kraiss LW, McKellar SH, Koliopoulou A, Brooke BS, Selzman CH, Glotzbach J (2020). Aortic disease in the time of COVID-19 and repercussions on patient care at an academic aortic center. Journal of vascular surgery, 72(2), 408-413.
  15. Hess JA, Hanson KE, Selzman CH, Stehlik (2017). Arterial Thrombus in a Heart Transplant Recipient. American journal of transplantation, 17(1), 300-302.
  16. Koliopoulou A, Selzman C (2017). Stop the LVAD bleeding. Journal of thoracic disease, 9(5), E437-E439.
  17. Stehlik J, Johnson SA, Selzman C (2015). Gold standard in anticoagulation assessment of left ventricular assist device patients?: how about bronze. JACC. Heart failure, 3(4), 323-6.
  18. Selzman C (2009). Invited commentary on "In-hospital outcomes of off-pump multi-vessel total arterial and conventional artery bypass grafting: single surgeon, single center experience". 88, 53.
  19. DiChiacchio L, Goodwin ML, Kagawa H, Selzman C (2023). Commentary: Trainee or trainer?. The Journal of thoracic and cardiovascular surgery, 166(3), 902-903.
  20. Selzman C (2021). Commentary: Heart recovery: License to be offensive-on myocardial recovery following durable left ventricular assist device support. JTCVS open, 8, 6-7.
  21. Goodwin ML, Kagawa H, Selzman C (2021). The good, the bad, the ugly: Optimal left ventricular assist device duration in bridge to transplantation. JTCVS open, 8, 116-120.

Letter

  1. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos S (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. Circulation, 140(1), 98-100.
  2. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos S (2013). Reply: left ventricular assist devices in chronic heart failure: more questions than answers?. Journal of the American College of Cardiology, 62(23), 2257-8.
  3. Diakos NA, Selzman CH, Stehlik J, Sachse FB, Kfoury AG, Koliopoulou A, McKellar S, Fang JC, Li DY, Drakos S (2015). Reply: does size matter? In search of a physiological definition of myocardial atrophy. Journal of the American College of Cardiology, 65(19), 2156-7.
  4. Siokatas G, Hamouche R, Maneta E, Selzman C, Hatzistergos KE, Drakos SG, Drosatos (2024). Myocardial Krüppel-Like Factor 5 Abundance Holds Prognostic Value for Myocardial Recovery of Patients With Heart Failure Following Mechanical Unloading and Circulatory Support. Journal of the American Heart Association, 13(16), e035661.

Other

  1. Atluri P, Silvestry SC, Teuteberg JJ, Milano CA, Selzman CH, Cowger J (2022). What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted. ASAIO journal (American Society for Artificial Internal Organs, 68(2), 178-183.
  2. Lee YS, Javan H, Reems JA, Li L, Lusty J, Schaaf CI, Pierce J, Phillips JD, Selzman C (2022). Acellular human amniotic fluid protects the ischemic-reperfused rat myocardium. American journal of physiology. Heart and circulatory physiology, 322(3), H406-H416.

Video/Film/CD/Web/Podcast

  1. Selzman C (2008). Off-pump insertion of the Jarvik 2000 Left Ventricular Assist Device.
  2. Selzman C (2012). Left Ventricular Assist Device Insertion.

News & Podcasts

News

Podcasts